“Two-phase”的搜索结果，显示 101-110 项，共有 2957 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Phase 1/2 study in a selected cohort of patient with LM. A Study to Assess Endometrial Cancer Recurrence in Patients After 36 Months. Rochester, Minn. The ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... phase 2 dose (RP2D) of APG-2575. Ado-trastuzumab emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2-positive Breast Cancer Patients. Rochester, Minn ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of ... Stage II (high risk)/Stage III colon cancer. Pagination 临床研究. Prev ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

6. 神经科- 临床试验- 妙佑医疗国际

   ... Phase 2 Dose (RP2D) of NMS-03305293 in combination with temozolomide (TMZ) in patients with diffuse gliomas at first relapse (Phase I), and to determine the ...

7. 泌尿科- 临床试验- 妙佑医疗国际

   Rochester, Minn. This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations. It efficiently examines a ...

8. 泌尿科- 临床试验- 妙佑医疗国际

   Rochester, Minn. This is an international phase III trial, with a Bayesian design, incorporating two sequential randomisations. It efficiently examines a ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab ... Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC. Rochester, Minn ...

10. 脑肿瘤项目- 临床试验- 妙佑医疗国际

    The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...